Research progress on hematological markers of cognitive impairment in
patients with cerebral small vessel disease

doi:10.3760/cma.j.issn.1007-1245.2022.11.033

Abstract

Abstract: Nowadays, vessel cognitive impairment (VCI) has become the second leading cause of dementia, and cerebral small vessel disease (CSVD) is recognized as the most common cause of VCI. In clinical practice, the diagnosis of cognitive impairment of cerebrovascular disease (CSVCI) is mainly based on the evaluation of neurological scale and neuroimaging, and the diagnosis is obtained after excluding cognitive impairment caused by other diseases. In recent years, due to the increasingly mature detection technology of hematological markers, many scholars believe that hematological marker detection is a simple and practical detection method, and provides important references for the clinical diagnosis of CSVCI, so as to intervene CSVCI in the early stage. This paper reviews the research progress of CSVCI hematological markers in recent 10 years.

Key words: Cerebral small vessel disease, Cognitive impairment, Blood biomarkers

摘要： 如今，血管性认知障碍（vessel cognitive impairment，VCI）已成为痴呆的第2大病因，其中脑小血管病（cerebral small vessel disease，CSVD）被公认为VCI最常见的病因。临床实践中，脑小血管病认知功能障碍（CSVCI）的诊断主要通过神经量表评估、神经影像学等检查，并排除其他疾病导致认知功能障碍后得出诊断。近年来，因血液学标志物检测技术愈加成熟。众多学者认为，血液学标志物检测是一种简便、实用的检测手段，为CSVCI的临床诊断提供重要的参考价值，以此早期对CSVCI进行干预。本文主要对近10年CSVCI血液学标志物的研究进展作一综述。

关键词: 脑小血管病, 认知障碍, 血液学标志物

Xie Rongji, Liu Zhou, Zhao Bin. Research progress on hematological markers of cognitive impairment in patients with cerebral small vessel disease[J]. International Medicine and Health Guidance News, 2022, 28(11): 1619-1624.

谢荣基, 刘洲, 赵斌. 脑小血管病性认知障碍血液学标志物的研究进展[J]. 国际医药卫生导报, 2022, 28(11): 1619-1624.

References

[1] Cai Z, Wang C, He W, et al. Cerebral small vessel disease and Alzheimer's disease[J]. Clin Interv Aging, 2015, 23(10):1695-1704. DOI:10.2147/CIA.S90871.

[2] Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic wholebra in disease[J].Stroke Vasc Neurol,2016,1(3):83-92. DOI:10.1136/svn-2016-000035.

[3] Chen L, Chen L, Lv Y, et al. Tetrandrine ameliorates cognitive impairment via inhibiting astrocyte-derived S100B activation in a rat model of chronic cerebral hypoperfusion[J]. Neurol Res 2013,35(6):614–621. DOI:10.1179/1743132813Y.0000000175.

[4] Wang F, Zou ZR, Yuan D, et al. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study[J]. Biosci Rep, 2017,37(2):BSR20160446. DOI:10.1042/BSR20160446.

[5] 张颖,张春丽,李璐,等.血清尿酸及S100β水平对脑小血管病轻度认知功能障碍的预测价值[J].中西医结合心脑血管病杂志,2021,19(3):495-497. DOI:10.12102/j.issn.1672- 1349.2021.03.032.

[6] Dobrynina LA, Alexandrova EV, Zabitova MR, et al. Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease[J]. Clinical biochemistry vol. 2021 ,96:26-32. DOI:10.1016/j.clinbiochem.2021.07.003.

[7] Wang Y, Lu W, Ning W, et al. Decreased levels of serum IL-34 associated with cognitive impairment in vascular dementia[J]. Biomed Res Int,2021,21: 6793860. DOI:10.1155/2021/6793860.

[8] Zhu S, Wei X, Yang X, et al. Plasma lipoprotein-associated phospholipase A2 and superoxide dismutase are independent predicators of cognitive impairment in cerebral small vessel disease patients: diagnosis and assessment[J]. Aging Dis, 2019,10(4):834-846. DOI:10.14336/AD.2019.0304.

[9] 牛雪芬,王雅楠,刘斌,等.基质金属蛋白酶9和脂蛋白相关磷脂酶A2与缺血性脑小血管病认知障碍的相关性[J].中华老年心脑血管病杂志,2020,22(6):621-624. DOI:10.3969/j.issn.1009-0126.2020.06.016.

[10] Kiyota T, Gendelman HE, Weir RA, et al. CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease[J].Neurobiol Aging,2013,34(4):1060-1068. DOI:10.1016/j.neurobiolaging.2012.08.009.

[11] Lee WJ, Liao YC, Wang YF, et al. Plasma MCP-1 and cognitive decline in patients with Alzheimer's disease and mild cognitive impairment: a two-year follow-up study[J]. Sci Rep,2018 ,8(1):1280. DOI:10.1038/s41598-018- 19807-y.

[12] Fornai F, Carrizzo A, Forte M, et al. The inflammatory protein Pentraxin 3 in cardiovascular disease[J]. Immun Ageing, 2016,13(1):25. DOI:10.1186/s12979-016-0080-1.

[13] 牛雪芬,刘斌,王雅楠,等.单核细胞趋化蛋白-1、正五聚蛋白3与脑小血管病认知障碍的相关性研究[J].兰州大学学报(医学版),2021,47(2):45-48,53. DOI:10.13885/j.issn.1000-2812.2021.02.008.

[14] D'Souza MM, Gorthi SP, Vadwala K, et al. Diffusion tensor tractography incerebral small vessel disease: correlation with cognitive function[J]. Neuroradiol J, 2018,31(1):83-89. DOI:10.1177/1971400916682753.

[15] Li Y, Chen L, Yao S, et al. Association of polymorphisms of the matrix metalloproteinase 9 gene with ischaemic stroke in a southern Chinese population [J]. Cell Physiol Biochem,2018;49(6):2188-2199. DOI:10.1159/000493823.

[16] 赵玲,崔素敏,郭威,等.脑小血管病认知功能损害与血管炎性因子的相关性分析[J].临床合理用药杂志,2014,(34):80-81. DOI:10.3969/j.issn.1674-3296.2014.34.067.

[17] Kielstein JT, Donnerstag F, Gasper S, et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans[J]. Stroke,2006,37(8):2024-2029. DOI:10.1161/01.STR.0000231640.32543.11.

[18] Gao Q, Fan Y, Mu LY, et al. S100B and ADMA in cerebral small vessel disease and cognitive dysfunction[J]. J Neurol Sci, 2015, 354(1-2):27-32. DOI:10.1016/j.jns.2015. 04.031.

[19] Wang Q, Deng Y, Huang L, et al. Hypertonic saline downregulates endothelial cell-derived VEGF expression and reduces blood-brain barrier permeability induced by cerebral ischaemia via the VEGFR2/eNOS pathway[J].Int JMol Med,2019,44(3):1078-1090.DOI:10.3892/ijmm.2019.4262.

[20] Freese C, Hanada S, Fallier-Becker P, et al. Identification of neuronal and angiogenic growth factorsin an in vitro blood-brain barrier model system: relevance in barrier integrity and tight junction formation and complexity[J]. Microvasc Res, 2017,111:1-11. DOI:10.1016/j.mvr.2016. 12.001.

[21] 郭霞,孙洪英,雍雯,等.脑小血管病认知障碍与血清VEGF及PEDF的相关性研究[J]. 重庆医科大学学报,2021,11:1360-1365. DOI:10.13406/j.cnki.cyxb.002911.

[22] Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis[J]. Arterioscler Thromb Vasc Biol, 2017,37(3): e13-e21. DOI:10.1161/ATVBAHA.117. 308564.

[23] Halaby R, Popma CJ, Cohen A, et al. D-Dimer elevation and adverse outcomes[J]. J Thromb Thrombolysis,2015,39(1):55-59. DOI:10.1007/s11239-014-1101-6.

[24] Faraco, G, Wang, G, Santisteban, M, et al. Abstract TMP94: dietary salt impairs cognitive function through suppression of endothelial nitric oxide synthesis and hippocampal BDNF signaling[J].Stroke,2018,49(1):ATMP94. DOI:10.1161/str.49.suppl_1.tmp94.

[25] Freeman BD, Martins YC, Akide-Ndunge OB, et al. Endothelin-1 mediates brain microvascular dysfunction leading to long-term cognitive impairment in a model of experimental cerebral malaria[J].PLoS Pathog,2016, 12(3):e1005477.DOI:10.1371/journal.ppat.1005477.

[26] 王雅楠,范少凯,牛雪芬,等.缺血性脑小血管病患者一氧化氮、内皮素-1和尿酸与血管性认知障碍的相关性[J].中国煤炭工业医学杂志,2019,22(5):463-468.DOI:10.11723/mtgyyx1007-9564201905004

[27] Westwood AJ, Beiser A, Decarli C, et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy[J]. Neurology,2014,82(18):1613-1619. DOI:10.1212/WNL.0000000000000382

[28] Kang J, Luo W, Zhang C, et al. Positive association between serum insulin-like growth factor-1 and cognition in patients with cerebral small vessel disease[J]. J Stroke Cerebrovasc Dis, 2021,30(7):105790. DOI:10.1016/j.jstrokecerebrovasdis.2021.105790.

[29] Unger G, Benozzi SF, Perruzza F, et al. Triglycerides and glucose index: a useful indicator of insulin resistance [J]. Endocrinol Nutr, 2014, 61(10):533-540. DOI:10.1016/j.endonu.2014.06.009.

[30] Yang X, Zhang S, Dong Z, et al. Insulin resistance is a risk factor for overall cerebral small vessel disease burden in old nondiabetic healthy adult population [J]. Front Aging Neurosci, 2019, 11:127. DOI:10.3389/fnagi.2019.00127.

[31] Ekblad LL, Rinne JO, Puukka P, et al. Insulin resistance predicts cognitive decline: an 11-year follow-up of a nationally representative adult population sample [J]. Diabetes Care, 2017, 40(6):751-758. DOI:10.2337/dc16-2001.

[32] 郭啸鸣,陆珍辉,曹志勇,等.甘油三酯-葡萄糖指数与60岁及以上脑小血管病患者血管性认知障碍的相关性分析[J].中华全科医师杂志,2021,20(9):984-989. DOI:10.3760/cma.j.cn114798-20210529-00425.

[33] Jiang T, Zhou Y, Zhang D, et al. Association of serum interleukin-34 and insulin resistance with cognitive impairment in patients with cerebral small vessel disease [J]. Curr Neurovasc Res, 2021, 18(4):446-455. DOI:10.2174/1567202618666211110113323.

[34] 张艳杰,杜敢琴,郭金朋,等.高压氧对一氧化碳中毒迟发脑病干预作用[J].中华急诊医学杂志,2018,27(7):794-798. DOI:10.3760/cma.j.issn.1671-0282.2018.07.017.

[35] 郑全乐,付娜,周顺义,等.急性一氧化碳中毒迟发性脑病的诊疗进展[J].中华神经创伤外科电子杂志,2017,3(1):48-5023. DOI:10.3877/cma.j.issn.2095-9141. 2017.01.012.

[36] 张重阳,吕喆,王耀辉,等.亚低温通过p38MAPK信号通路调控CPR大鼠脑组织AQP4表达并减轻脑水肿[J].中华危重病急救医学,2019,31(4):480-483. DOI:10.3760/cma.j.issn.2095-4352.2019.04.021.

[37] 刘平国,战涛,赵中.脑小血管病患者血清Klotho,FGF23表达水平变化与疾病进展及认知功能障碍的相关性分析[J].卒中与神经疾病,2021,28(5):539-542,555. DOI:10.3969/j.issn.1007-0478.2021.05.010.

[38] Peters N, van Leijsen E, Tuladhar AM, et al. Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease [J]. Stroke, 2020, 22(3):369-376. DOI:10.5853/jos.2019. 02845.

[39] Egle M, Loubiere L, Maceski A, et al. Neurofilament light chain predicts future dementia risk in cerebral small vessel disease [J]. J Neurol Neurosurg Psychiatry, 2021, 92(6):582-589. DOI:10.1136/jnnp-2020-325681.

[40] Jack CR, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease [J]. Alzheimers Dement, 2018, 14(4): 535-562. DOI:10.1016/j.jalz.2018.02.018.

[41] Counts SE, Ikonomovic MD, Mercado N, et al. Biomarkers for the early detection and progression of Alzheimer's disease [J]. Neurotherapeutics, 2017, 14(1):35-53. DOI:10.1007/s13311-016-0481-z.

[42] Liu J, Zhao W, Gui Q, et al. Addition of Aβ42 to total cerebral small vessel disease score improves the prediction for cognitive impairment in cerebral small vessel disease patients[J]. Neuropsychiatr Dis Treat, 2021, 17: 195-201. DOI:10.2147/NDT.S289357.

[43] Jang H, Kim HJ, Park S, et al. Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients[J]. Eur J Nucl Med Mol Imaging, 2020, 47(2): 292-303. DOI:10.1007/s00259-019-04498-y.

[44] 崔颖,刘斌,董亚楠,等.缺血性脑小血管病患者脂蛋白a、纤维蛋白原和D-二聚体与血管性认知障碍的相关性[J].中华行为医学与脑科学杂志,2019,28(4):331-336.DOI:10.11723/mtgyyx1007-9564201905004.

[45] 王学颖,王洪权,赵伟丽.脑小血管病患者认知功能障碍与血尿酸、同型半胱氨酸水平相关性研究[J].神经损伤与功能重建,2019,14(7):360-361,373.DOI:10.16780/j.cnki.sjssgncj.2019.07.010.

[46] Wang T, Sun ZW, Shao LQ, et al. Diagnostic values of serum levels of homocysteine and uric acid for predicting vascular mild cognitive impairment in patients with cerebral small vessel sisease[J]. Med Sci Monit, 2017, 23:2217-2225. DOI: 10.12659/msm.901652.

[47] 孟颖,王大巍.缺血性脑小血管病患者血清碱性磷酸酶、胱抑素C的变化与认知功能障碍的相关性分析[J].齐齐哈尔医学院学报,2021,42(16):1395-1398. DOI:10.3969/j.issn.1002-1256.2021.16.004.

[48] Jiang C, Zou X, Zhu R, et al. The correlation between accumulation of amyloid beta with enhanced neuroinflammation and cognitive impairment after intraventricular hemorrhage[J]. J Neurosurg, 2018, 131(1):54-63. DOI:10.3171/2018.1.JNS172938.

[49] Yoo JS, Ryu CH, Kim YS, et al. Homocysteinemia is associated with the presence of microbleeds in cognitively impaired patients[J]. J Stroke Cerebrovasc Dis, 2020, 29(12):105302. DOI:10.1016/j.jstrokecerebrovasdis. 2020.105302.

[50] Lan TY, Cui DY, Liu TT, et al. Correlation of serum ferritin levels with neurological function-related indices and cognitive dysfunction in patients with cerebral hemorrhage[J]. Clin Neuropathol, 2021,40(6): 333-340. DOI:10.5414/NP301368.

Research progress on hematological markers of cognitive impairment in patients with cerebral small vessel disease

脑小血管病性认知障碍血液学标志物的研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

[1]	Gong Chen, Shen Xiaozhu, Bao Qinwen, Zhao Xiaofei. Correlation between vitamin D level and cognitive dysfunction in elderly patients with cerebral small vessel disease [J]. International Medicine and Health Guidance News, 2022, 28(8): 1081-1085.
[2]	Ji Haiyan, Tang Qingrong, Qiao Jubo. Influencing factors of post-stroke cognitive impairment [J]. International Medicine and Health Guidance News, 2022, 28(1): 15-18.
[3]	Shao Keke, Ru Wenwen. Randomized controlled study of amantadine combined with dalingfu in the treatment of patients with Parkinson's disease [J]. International Medicine and Health Guidance News, 2021, 27(6): 881-884.